CDG2N
MCID: CNG498
MIFTS: 37

Congenital Disorder of Glycosylation, Type Iin (CDG2N)

Categories: Blood diseases, Bone diseases, Cardiovascular diseases, Ear diseases, Endocrine diseases, Eye diseases, Fetal diseases, Gastrointestinal diseases, Genetic diseases, Immune diseases, Liver diseases, Mental diseases, Metabolic diseases, Muscle diseases, Nephrological diseases, Neuronal diseases, Rare diseases, Skin diseases

Aliases & Classifications for Congenital Disorder of Glycosylation, Type Iin

MalaCards integrated aliases for Congenital Disorder of Glycosylation, Type Iin:

Name: Congenital Disorder of Glycosylation, Type Iin 58 76 30 6
Cdg2n 58 12 60 76
Congenital Disorder of Glycosylation Type Iin 12 60 15
Cdg Iin 58 12 76
Carbohydrate Deficient Glycoprotein Syndrome Type Iin 12 60
Congenital Disorder of Glycosylation Type 2n 12 60
Cdg Syndrome Type Iin 12 60
Slc39a8-Cdg 12 60
Cdg-Iin 60 76
Cdgiin 58 76
Congenital Disorder of Glycosylation 2n 76
Slc39a8 Deficiency 60
Cdg Iin; Cdgiin 58
Cdgiidn 12

Characteristics:

OMIM:

58
Inheritance:
autosomal recessive

Miscellaneous:
onset at birth


HPO:

33
congenital disorder of glycosylation, type iin:
Onset and clinical course congenital onset
Inheritance autosomal recessive inheritance


Classifications:



Summaries for Congenital Disorder of Glycosylation, Type Iin

UniProtKB/Swiss-Prot : 76 Congenital disorder of glycosylation 2N: A form of congenital disorder of glycosylation, a genetically heterogeneous group of autosomal recessive, multisystem disorders caused by a defect in glycoprotein biosynthesis and characterized by under-glycosylated serum glycoproteins. Congenital disorders of glycosylation result in a wide variety of clinical features, such as defects in the nervous system development, psychomotor retardation, dysmorphic features, hypotonia, coagulation disorders, and immunodeficiency. The broad spectrum of features reflects the critical role of N-glycoproteins during embryonic development, differentiation, and maintenance of cell functions.

MalaCards based summary : Congenital Disorder of Glycosylation, Type Iin, also known as cdg2n, is related to dystonia and hypermanganesemia with dystonia. An important gene associated with Congenital Disorder of Glycosylation, Type Iin is SLC39A8 (Solute Carrier Family 39 Member 8), and among its related pathways/superpathways are NRF2 pathway and Metal ion SLC transporters. Affiliated tissues include skin, liver and bone, and related phenotypes are osteopenia and seizures

Disease Ontology : 12 A congenital disorder of glycosylation type II that has material basis in an autosomal recessive mutation of SLC39A8 on chromosome 4q24.

OMIM : 58 Congenital disorder of glycosylation type IIn (CDG2N) is an autosomal recessive severe multisystem developmental disorder characterized by delayed psychomotor development apparent from infancy, hypotonia, and variable additional features, such as short stature, seizures, visual impairment, and cerebellar atrophy. Serum transferrin analysis shows a CDG type II pattern (summary by Boycott et al., 2015 and Park et al., 2015). For a discussion of genetic heterogeneity of CDG type II, see CDG2A (212066). (616721)

Related Diseases for Congenital Disorder of Glycosylation, Type Iin

Diseases in the Congenital Disorder of Glycosylation, Type Ii family:

Congenital Disorder of Glycosylation, Type Ia Congenital Disorder of Glycosylation, Type Iia
Congenital Disorder of Glycosylation, Type I/iix Congenital Disorder of Glycosylation, Type Iic
Congenital Disorder of Glycosylation, Type Iim Congenital Disorder of Glycosylation, Type Iy
Congenital Disorder of Glycosylation, Type Id Congenital Disorder of Glycosylation, Type Ib
Congenital Disorder of Glycosylation, Type Ic Congenital Disorder of Glycosylation, Type Iif
Congenital Disorder of Glycosylation, Type Iib Congenital Disorder of Glycosylation, Type Iid
Congenital Disorder of Glycosylation, Type Ig Congenital Disorder of Glycosylation, Type Ij
Congenital Disorder of Glycosylation, Type Ih Congenital Disorder of Glycosylation, Type Ik
Congenital Disorder of Glycosylation, Type Il Congenital Disorder of Glycosylation, Type Ie
Congenital Disorder of Glycosylation, Type if Congenital Disorder of Glycosylation, Type Im
Congenital Disorder of Glycosylation, Type Iih Congenital Disorder of Glycosylation, Type Iig
Congenital Disorder of Glycosylation, Type in Congenital Disorder of Glycosylation, Type Iq
Congenital Disorder of Glycosylation, Type Iij Congenital Disorder of Glycosylation, Type Iii
Congenital Disorder of Glycosylation, Type Ip Congenital Disorder of Glycosylation, Type Ir
Congenital Disorder of Glycosylation, Type Iil Congenital Disorder of Glycosylation, Type Iik
Congenital Disorder of Glycosylation, Type It Congenital Disorder of Glycosylation, Type Iu
Congenital Disorder of Glycosylation, Type Iw Congenital Disorder of Glycosylation, Type Ix
Congenital Disorder of Glycosylation, Type Iin Congenital Disorder of Glycosylation, Type Iio
Congenital Disorder of Glycosylation, Type Iip Congenital Disorder of Glycosylation, Type Iiq

Diseases related to Congenital Disorder of Glycosylation, Type Iin via text searches within MalaCards or GeneCards Suite gene sharing:

# Related Disease Score Top Affiliating Genes
1 dystonia 9.7 SLC30A10 SLC39A14
2 hypermanganesemia with dystonia 9.5 SLC30A10 SLC39A14

Symptoms & Phenotypes for Congenital Disorder of Glycosylation, Type Iin

Human phenotypes related to Congenital Disorder of Glycosylation, Type Iin:

33 (show all 16)
# Description HPO Frequency HPO Source Accession
1 osteopenia 33 occasional (7.5%) HP:0000938
2 seizures 33 occasional (7.5%) HP:0001250
3 hearing impairment 33 occasional (7.5%) HP:0000365
4 joint hypermobility 33 occasional (7.5%) HP:0001382
5 recurrent infections 33 occasional (7.5%) HP:0002719
6 craniosynostosis 33 occasional (7.5%) HP:0001363
7 cerebral atrophy 33 occasional (7.5%) HP:0002059
8 nystagmus 33 HP:0000639
9 global developmental delay 33 HP:0001263
10 short stature 33 HP:0004322
11 strabismus 33 HP:0000486
12 inability to walk 33 HP:0002540
13 intellectual disability, profound 33 HP:0002187
14 cerebellar atrophy 33 HP:0001272
15 astigmatism 33 HP:0000483
16 generalized hypotonia 33 HP:0001290

Symptoms via clinical synopsis from OMIM:

58
Head And Neck Eyes:
nystagmus
strabismus
astigmatism
poor visual fixation (in some patients)

Neurologic Central Nervous System:
inability to walk
intellectual disability, profound
cerebellar atrophy
seizures (in some patients)
delayed psychomotor development, profound
more
Skeletal:
osteopenia (in some patients)
joint hypermobility (in some patients)

Head And Neck Ears:
hearing loss (1 patient)

Laboratory Abnormalities:
serum transferrin glycosylation defect in a type ii pattern
decreased plasma zinc and manganese
increased urinary zinc and manganese (in some patients)

Growth Height:
short stature

Immunology:
recurrent infections (in some patients)

Skeletal Skull:
craniosynostosis (1 patient)

Muscle Soft Tissue:
hypotonia, profound

Clinical features from OMIM:

616721

Drugs & Therapeutics for Congenital Disorder of Glycosylation, Type Iin

Search Clinical Trials , NIH Clinical Center for Congenital Disorder of Glycosylation, Type Iin

Genetic Tests for Congenital Disorder of Glycosylation, Type Iin

Genetic tests related to Congenital Disorder of Glycosylation, Type Iin:

# Genetic test Affiliating Genes
1 Congenital Disorder of Glycosylation, Type Iin 30 SLC39A8

Anatomical Context for Congenital Disorder of Glycosylation, Type Iin

MalaCards organs/tissues related to Congenital Disorder of Glycosylation, Type Iin:

42
Skin, Liver, Bone, Eye

Publications for Congenital Disorder of Glycosylation, Type Iin

Articles related to Congenital Disorder of Glycosylation, Type Iin:

# Title Authors Year
1
Autosomal-Recessive Intellectual Disability with Cerebellar Atrophy Syndrome Caused by Mutation of the Manganese and Zinc Transporter Gene SLC39A8. ( 26637978 )
2015
2
SLC39A8 Deficiency: A Disorder of Manganese Transport and Glycosylation. ( 26637979 )
2015

Variations for Congenital Disorder of Glycosylation, Type Iin

UniProtKB/Swiss-Prot genetic disease variations for Congenital Disorder of Glycosylation, Type Iin:

76
# Symbol AA change Variation ID SNP ID
1 SLC39A8 p.Val33Met VAR_076241 rs373562040
2 SLC39A8 p.Gly38Arg VAR_076242 rs778210210
3 SLC39A8 p.Gly204Cys VAR_076243 rs779241085
4 SLC39A8 p.Ser335Thr VAR_076244 rs864309660
5 SLC39A8 p.Ile340Asn VAR_076245 rs864309659

ClinVar genetic disease variations for Congenital Disorder of Glycosylation, Type Iin:

6
# Gene Variation Type Significance SNP ID Assembly Location
1 SLC39A8 NM_022154.5(SLC39A8): c.112G> C (p.Gly38Arg) single nucleotide variant Pathogenic rs778210210 GRCh38 Chromosome 4, 102344551: 102344551
2 SLC39A8 NM_022154.5(SLC39A8): c.112G> C (p.Gly38Arg) single nucleotide variant Pathogenic rs778210210 GRCh37 Chromosome 4, 103265708: 103265708
3 SLC39A8 NM_022154.5(SLC39A8): c.1019T> A (p.Ile340Asn) single nucleotide variant Uncertain significance rs864309659 GRCh37 Chromosome 4, 103189058: 103189058
4 SLC39A8 NM_022154.5(SLC39A8): c.1019T> A (p.Ile340Asn) single nucleotide variant Uncertain significance rs864309659 GRCh38 Chromosome 4, 102267901: 102267901
5 SLC39A8 NM_022154.5(SLC39A8): c.610G> T (p.Gly204Cys) single nucleotide variant Uncertain significance rs779241085 GRCh37 Chromosome 4, 103226211: 103226211
6 SLC39A8 NM_022154.5(SLC39A8): c.610G> T (p.Gly204Cys) single nucleotide variant Uncertain significance rs779241085 GRCh38 Chromosome 4, 102305054: 102305054
7 SLC39A8 NM_022154.5(SLC39A8): c.1004G> C (p.Ser335Thr) single nucleotide variant no interpretation for the single variant rs864309660 GRCh38 Chromosome 4, 102267916: 102267916
8 SLC39A8 NM_022154.5(SLC39A8): c.1004G> C (p.Ser335Thr) single nucleotide variant no interpretation for the single variant rs864309660 GRCh37 Chromosome 4, 103189073: 103189073
9 SLC39A8 NM_022154.5(SLC39A8): c.97G> A (p.Val33Met) single nucleotide variant no interpretation for the single variant rs373562040 GRCh37 Chromosome 4, 103265723: 103265723
10 SLC39A8 NM_022154.5(SLC39A8): c.97G> A (p.Val33Met) single nucleotide variant no interpretation for the single variant rs373562040 GRCh38 Chromosome 4, 102344566: 102344566

Expression for Congenital Disorder of Glycosylation, Type Iin

Search GEO for disease gene expression data for Congenital Disorder of Glycosylation, Type Iin.

Pathways for Congenital Disorder of Glycosylation, Type Iin

Pathways related to Congenital Disorder of Glycosylation, Type Iin according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.32 SLC39A14 SLC39A8
2
Show member pathways
10.78 SLC30A10 SLC39A14 SLC39A8
3 10.56 SLC39A14 SLC39A8

GO Terms for Congenital Disorder of Glycosylation, Type Iin

Biological processes related to Congenital Disorder of Glycosylation, Type Iin according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 ion transport GO:0006811 9.54 SLC30A10 SLC39A14 SLC39A8
2 transmembrane transport GO:0055085 9.5 SLC30A10 SLC39A14 SLC39A8
3 cellular zinc ion homeostasis GO:0006882 9.26 SLC39A14 SLC39A8
4 metal ion transport GO:0030001 9.16 SLC39A14 SLC39A8
5 zinc ion import across plasma membrane GO:0071578 8.96 SLC39A14 SLC39A8
6 zinc ion transport GO:0006829 8.8 SLC30A10 SLC39A14 SLC39A8

Molecular functions related to Congenital Disorder of Glycosylation, Type Iin according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 zinc ion transmembrane transporter activity GO:0005385 8.96 SLC39A14 SLC39A8
2 metal ion transmembrane transporter activity GO:0046873 8.62 SLC39A14 SLC39A8

Sources for Congenital Disorder of Glycosylation, Type Iin

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
20 FMA
29 GO
30 GTR
31 HGMD
32 HMDB
33 HPO
34 ICD10
35 ICD10 via Orphanet
36 ICD9CM
37 IUPHAR
38 KEGG
39 LifeMap
41 LOVD
43 MedGen
45 MeSH
46 MESH via Orphanet
47 MGI
50 NCI
51 NCIt
52 NDF-RT
55 NINDS
56 Novoseek
58 OMIM
59 OMIM via Orphanet
63 PubMed
65 QIAGEN
70 SNOMED-CT via HPO
71 SNOMED-CT via Orphanet
72 TGDB
73 Tocris
74 UMLS
75 UMLS via Orphanet
Content
Loading form....